Get started
Author

Sarah Dingli

Observed institution: University of Minnesota
ORCID: 0009-0005-9308-7145
Observed ORCID: 0009-0005-9308-7145
OpenAlex ID: A5116556983
The ratio of brain to liver glucose activity and disease activity in multiple myeloma
2025 · Sarah Dingli, Paul Rothweiler, et al. · Blood Cancer Journal · 6
PDF
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma
2025 · Sarah Dingli, Paul Rothweiler, et al. · Leukemia · 4
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products
2025 · Sarah Dingli, Paul Rothweiler, et al. · American Journal of Hematology · 3
PDF
Basophilia and eosinophilia in primary myelofibrosis: phenotype, genotype, and prognostic correlates
2025 · Sarah Dingli, Saubia Fathima, et al. · Blood Cancer Journal · 2
PDF
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma
2025 · Sarah Dingli, Paul Rothweiler, et al. · Blood Cancer Journal · 1
PDF
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates
2025 · Priyansh Faldu, Muhammad Yousuf, et al. · Annals of Hematology · 1
PDF
Lymphocyte dynamics after CAR ‐T therapy for non‐Hodgkin lymphoma
2026 · Sarah Dingli, Paul Rothweiler, et al. · British Journal of Haematology
Works count: 7
Citation count: 17
H-index: 3
I10-index:
Year
Topic
Type